Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by ...
Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...
The "Genetic Testing Market by Type, Technology, Application: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com’s offering. The genetic ...
SAN DIEGO, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the publication of a study covering the analytical validation of its laboratory developed test (LDT), marketed as ...
(MENAFN- EIN Presswire) EINPresswire/ -- The global Molecular Cytogenetics Market is witnessing strong and sustained growth as precision diagnostics, oncology research, and genetic disorder screening ...
Identification of recurrent genetic abnormalities is important for disease evaluation, optimal risk stratification and treatment planning. Testing for recurrent genetic abnormalities should be ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...
Neuberg Sehgal Path Lab, a leading name in diagnostic services, has announces the launch of cutting-edge cytogenetics testing technology at its facilities in Mumbai. This advanced diagnostic tool is ...
(MEXICO CITY, April 8, 2011) – A workshop being held today will serve as the launch of a unique project that unites the American Society of Hematology (ASH), the Agrupación Mexicana para el Estudio de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results